9S2W | pdb_00009s2w

The structure of phosphoglucose isomerase in complex with deoxynojirimycin-6-phosphate and a fragment

  • Classification: ISOMERASE
  • Organism(s): Candida albicans
  • Expression System: Escherichia coli
  • Mutation(s): No 

  • Deposited: 2025-07-23 Released: 2026-08-12 
  • Deposition Author(s): Yan, K.
  • Funding Organization(s): Medical Research Council (MRC, United Kingdom), Wellcome Trust

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.70 Å
  • R-Value Free: 
    0.215 (Depositor), 0.215 (DCC) 
  • R-Value Work: 
    0.180 (Depositor), 0.180 (DCC) 
  • R-Value Observed: 
    0.181 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9S2W

Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history

Literature

Avenues to explore the selectivity of phosphoglucose isomerase inhibitors

Yan, K.Borodkin, V.Ferenbach, A.Fang, W.van Aalten, D.

To be published.

Macromolecule Content 

  • Total Structure Weight: 124.65 kDa 
  • Atom Count: 9,408 
  • Modeled Residue Count: 1,100 
  • Deposited Residue Count: 1,110 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Glucose-6-phosphate isomerase
A, B
555Candida albicansMutation(s): 0 
Gene Names: PGI1CAALFM_CR06340CACaO19.11369CaO19.3888
EC: 5.3.1.9 (PDB Primary Data), 5.1.3 (UniProt)
UniProt
Find proteins for P83780 (Candida albicans (strain SC5314 / ATCC MYA-2876))
Explore P83780 
Go to UniProtKB:  P83780
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP83780
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1JCV
(Subject of Investigation/LOI)

Query on A1JCV



Download:Ideal Coordinates CCD File
F [auth A],
K [auth B]
[(2~{R},3~{R},4~{R},5~{S})-3,4,5-tris(oxidanyl)piperidin-2-yl]methyl dihydrogen phosphate
C6 H14 N O7 P
GDNPQORLESVKIU-JGWLITMVSA-N
IRU
(Subject of Investigation/LOI)

Query on IRU



Download:Ideal Coordinates CCD File
C [auth A]
D [auth A]
E [auth A]
G [auth A]
H [auth B]
C [auth A],
D [auth A],
E [auth A],
G [auth A],
H [auth B],
I [auth B],
J [auth B],
L [auth B]
1~{H}-pyrazol-5-ylmethanol
C4 H6 N2 O
UIEABCXJWANXFS-UHFFFAOYSA-N
CL

Query on CL



Download:Ideal Coordinates CCD File
M [auth B]CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.70 Å
  • R-Value Free:  0.215 (Depositor), 0.215 (DCC) 
  • R-Value Work:  0.180 (Depositor), 0.180 (DCC) 
  • R-Value Observed: 0.181 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 87.37α = 90
b = 101.499β = 90
c = 138.913γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
autoPROCdata reduction
Aimlessdata scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data

  • Released Date: 2026-08-12 
  • Deposition Author(s): Yan, K.

Funding OrganizationLocationGrant Number
Medical Research Council (MRC, United Kingdom)United KingdomMR/V001094/1
Wellcome TrustUnited Kingdom200208/Z/15/Z

Revision History  (Full details and data files)

  • Version 1.0: 2026-08-12
    Type: Initial release